DNA Chat Corporation

Technology to enable DNA based precision medicine in each doctor's visits

Print
Claim My Business
View on Wefunder
Categories
Technology, Healthcare & Medical, Other, Health & Fitness, Financial Services
Min Investment
$100
Location
New York, , NY
No. Investors
45
Website
mendlycare.com

Key Deal Facts

First to enable the use of DNA sequencing in each doctor's visit
8-30x cost advantage for companies with self-insured healthcare
Patent pending DNA Hyper-sharding technology
Prevents 5-year diagnostic odyssey with 2 doctor's visits
Everything is ready to sell — beta testing stage
Insurance and Benefits Broker partner locked
Founder with one successful exit
$23 Bn Total Addressable Market (TAM)

Management Team / Advisory Board Bios

Thiago Vincenzi ConradoFounder & CEOMaster and PhD in Genetics, Dupont-Pionner Research Manager, successful exit last startup, 20 years of accumulated experience of genetics and blockchain, Jack LangbergCo-Founder & Lead DevManaged >$100M in crypto staking, NYU Computer Science and Mathematics, Glenn LangbergStrategic AdvisorC-level executive, currently CSO at Contract Pharmacal Corp and CEO of GRL Capital Companies. Clients -CVS, Walgreens, Cardinal Health, Sanofi, Bayer and Kenvue, Tais Fernanda RodriguesMedical Practice AdvisorFamily Medical Practice Expert
Amount Raised : $151,508
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment